Review: Neurochemical Aspects of Mental Health and Neurological Diseases
Digital Object Identifier:
10.58578/ajbmbr.v1i1.3473
Viewed : 95 times
Downloaded : 41 times
Please do not hesitate to contact us if you would like to obtain more information about the submission process or if you have further questions.
Abstract
Neurochemistry is the study of chemicals, including neurotransmitters, hormones, and other molecules, that influence the function and behavior of the nervous system. This field has evolved significantly since the early 20th century, driven by key discoveries and technological advancements such as Neurotransmitters and Mental Health, "Neurotransmitters like serotonin, dopamine, and norepinephrine are fundamental in regulating mood, cognition, and behavior. Disruptions in these systems are implicated in various psychiatric disorders". Also, Neurotransmitter Imbalances and Mental Disorders: this is the Alterations in neurotransmitter levels, such as serotonin and dopamine, are associated with the symptoms of depression and schizophrenia". Then the GABAergic dysfunction is linked to anxiety disorders, highlighting the role of inhibitory neurotransmission in mental health". As well as Role of Neurochemicals in Specific Disorders: where low serotonin levels are commonly found in individuals with depression, leading to the development of SSRIs as a treatment". The review also look into Schizophrenia which is associated with both hyperactivity and hypoactivity of dopamine pathways, which influences treatment strategies", as well as the Neurochemical Pathways and Mechanisms: The HPA axis plays a critical role in the stress response, and its dysregulation which is linked to mood disorders". Dopaminergic pathways, including the mesolimbic and nigrostriatal systems, are essential for reward and motor control" as well as the Neurotransmitter Receptors and Transporters, Serotonin receptors, such as 5-HT1A, are critical in mood regulation and are targeted by many antidepressants". The central point of disorder "Dopamine transporters are involved in the re-uptake of dopamine and are implicated in disorders like ADHD and addiction". Thus, Neuroinflammation and Mental Health: which Increased neuroinflammation is associated with depression, with elevated pro-inflammatory cytokines observed in affected individuals", "Microglia and their role in neuroinflammation and psychiatric disorders are all the key area of the research."
Citation Metrics:
Downloads
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
2. Zhou, Y., et al. (2013). The role of neurochemistry in mental health and neurological diseases. Neurobiology of Disease, 50, 1-10.
3. Stahl, S. M. (2000). Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press.
4. Nestler, E. J., et al. (2002). The neurobiology of depression. Neuron, 34(1), 13-25.
5. Hyman, S. E. (2009). The neurobiology of addiction: implications for voluntary control of behavior. American Journal of Psychiatry, 166(9), 942-944.
6. Reeves, A. J., et al. (2002). Neurochemical changes in Alzheimer’s disease: implications for pathogenesis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 73(5), 525-530.
7. Stahl, S. M. (2000). Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press.
8. Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry, 122(5), 509-522.
9. Nuss, P. (2015). Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatric Disease and Treatment, 11, 165-175.
10. Coppen, A. (1967). The biochemistry of affective disorders. British Journal of Psychiatry, 113(504), 1237-1264)
11. Grace, A. A. (2016). Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nature Reviews Neuroscience, 17(8), 524-532.
12. Holsboer, F. (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 23(5), 477-501.
13. Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28(3), 309-369.
14. Savitz, J., et al. (2009). The Kynurenine Pathway: a link between immunity and depression. Molecular Psychiatry, 14(4), 336-353.
15. Fleckenstein, A. E., et al. (2007). New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology, 47, 681-698.
16. Miller, A. H., et al. (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65(9), 732-741.
17. Perry, V. H., et al. (2010). The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective. Nature Reviews Neuroscience, 11(3), 189-198.
18. 2. Peng, Z.D., Lisanby, S.H. & Peterchev, A.V., 2013. Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs. Brain Stimulation, 6(1), pp.1-13.
19. Kobayashi, M. & Pascual-Leone, A., 2003. Transcranial magnetic stimulation in neurology. Lancet Neurology, 2(3), pp.145-156.
20. Klomjai, W., Katz, R. & Lackmy-Vallée, A., 2015. Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Annals of Physical and Rehabilitation Medicine, 58(4), pp.208-213.
21. Richieri, R., Boyer, L., Padovani, R., et al., 2012. Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS. Progress in Neuropsychopharmacology and Biological Psychiatry, 39(2), pp.364-370.
22. Yamanaka, K., Tomioka, H., Kawasaki, S., et al., 2014. Effect of parietal transcranial magnetic stimulation on spatial working memory in healthy elderly persons - comparison of near infrared spectroscopy for young and elderly. PLoS One, 9(7), e102306.
23. Lenz, M., Galanis, C., Muller-Dahlhaus, F., et al., 2016. Repetitive magnetic stimulation induces plasticity of inhibitory synapses. Nature Communications, 7, 10020.
24. Su, L., Cai, Y., Xu, Y., Dutt, A., Shi, S. & Bramon, E., 2014. Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry, 14, 321.
25. Beynel, L., Appelbaum, L.G., Luber, B., et al., 2019. Effects of online repetitive transcranial magnetic stimulation (rTMS) on cognitive processing: A meta-analysis and recommendations for future studies. Neuroscience and Biobehavioral Reviews, 107, pp.47-58.
26. Sathappan, A.V., Luber, B.M. & Lisanby, S.H., 2019. The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions. Progress in Neuropsychopharmacology and Biological Psychiatry, 89, pp.347-360.
27. Khedr, E.M., Rothwell, J.C., Shawky, O.A., Ahmed, M.A. & Hamdy, A., 2006. Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Movement Disorders, 21(12), pp.2201-2205.
28. Mally, J., Farkas, R., Tothfalusi, L. & Stone, T.W., 2004. Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease. Brain Research Bulletin, 64(3), pp.259-263.
29. Pascual-Leone, A., Valls-Sole, J., Wassermann, E.M. & Hallett, M., 1994. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain, 117(Pt 4), pp.847-858.
30. Yang, C., Guo, Z., Peng, H., et al., 2018. Repetitive transcranial magnetic stimulation therapy for motor recovery in Parkinson's disease: A Meta-analysis. Brain and Behavior, 8(11), e01132.
31. Yokoe, M., Mano, T., Maruo, T., et al., 2018. The optimal stimulation site for high-frequency repetitive transcranial magnetic stimulation in Parkinson's disease: A double-blind crossover pilot study. Journal of Clinical Neuroscience, 47, pp.72-78.
32. González-García, N., Armony, J.L., Soto, J., Trejo, D., Alegría, M.A. & Drucker-Colín, R., 2011. Effects of rTMS on Parkinson’s disease: a longitudinal fMRI study. Journal of Neurology, 258(7), pp.1268-1280.
33. Alagona, G., Bella, R., Ferri, R., et al., 2001. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neuroscience Letters, 314(1–2), pp.57-60.
34. Julkunen, P., Jauhiainen, A.M., Westeren-Punnonen, S., et al., 2008. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study. Journal of Neuroscience Methods, 172(2), pp.270-276.
35. Bentwich, J., Dobronevsky, E., Aichenbaum, S., et al., 2011. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study. Journal of Neural Transmission (Vienna), 118(3), pp.463-471.
36. Zhao, J., Li, Z., Cong, Y., et al., 2017. Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients. Oncotarget, 8(20), pp.33864-33871.
37. Nguyen, J.P., Suarez, A., Kemoun, G., et al., 2017. Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease. Neurophysiology Clinical, 47(1), pp.47-53.
38. Alcala-Lozano, R., Morelos-Santana, E., Cortes-Sotres, J.F., Garza-Villarreal, E.A., Sosa-Ortiz, A.L. & Gonzalez-Olvera, J.J., 2018. Similar clinical improvement and maintenance after rTMS at 5 Hz using a simple vs. complex protocol in Alzheimer's disease. Brain Stimulation, 11(3), pp.625-627.
39. Lee, J., Choi, B.H., Oh, E., Sohn, E.H. & Lee, A.Y., 2016. Treatment of Alzheimer's disease with repetitive transcranial magnetic stimulation combined with cognitive training: a prospective, randomized, double-blind, placebo-controlled study. Journal of Clinical Neurology, 12(1), pp.57-64.
40. Rabey, J.M., Dobronevsky, E., Aichenbaum, S., Gonen, O., Marton, R.G. & Khaigrekht, M., 2013. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study. Journal of Neural Transmission (Vienna), 120(5), pp.813-819.
41. Chou, Y.H., Ton That, V. & Sundman, M., 2020. A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging, 86, pp.1-10.
42. Liao, X., Li, G., Wang, A., et al., 2015. Repetitive transcranial magnetic stimulation as an alternative therapy for cognitive impairment in Alzheimer's disease: a meta-analysis. Journal of Alzheimer's Disease, 48(2), pp.463-472.
43. Zhang, N., Xing, M., Wang, Y., Tao, H. & Cheng, Y., 2015. Repetitive transcranial magnetic stimulation enhances spatial learning and synaptic plasticity via the VEGF and BDNF-NMDAR pathways in a rat model of vascular dementia. Neuroscience, 311, pp.284-291.
44. Yang, H.Y., Liu, Y., Xie, J.C., Liu, N.N. & Tian, X., 2015. Effects of repetitive transcranial magnetic stimulation on synaptic plasticity and apoptosis in vascular dementia rats. Behavioral Brain Research, 281, pp.149-155.
45. Zhang, X.Q., Li, L., Huo, J.T., Cheng, M. & Li, L.H., 2018. Effects of repetitive transcranial magnetic stimulation on cognitive function and cholinergic activity in the rat hippocampus after vascular dementia. Neural Regeneration Research, 13(8), pp.1384-1389.
46. Rektorova, I., Megova, M., Bares, M. & Rektor, I., 2005. Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients. Journal of Neurological.
